COMMUNIQUÉS West-GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/01/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/01/2025
SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Rakovina Therapeutics to Connect with Industry Leaders During 43rd Annual J.P. Morgan Healthcare Conference Week
03/01/2025
VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics, Inc. (TSX: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on novel DNA-damage response [...]
Procaps Group Receives Additional Delinquency Letter
03/01/2025
MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today [...]
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/01/2025
SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
03/01/2025
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate of 52,188 shares of [...]
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
03/01/2025
SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an [...]
ACC Medlink Solidifies Leadership with 20% Expansion to Fleet of Mercedes Sprinter Vans
03/01/2025
PUNTA GORDA, Fla., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ACC Medlink, the undisputed leader in long-distance medical transportation, has announced a 20% expansion to its industry-leading fleet of luxurious Mercedes Sprinter [...]
Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03/01/2025
Media Release COPENHAGEN, Denmark; January 03, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 4 3 rd Annual J.P. Morgan Healthcare Conference [...]
VALNEVA Declaration of shares and voting rights: December 31, 2024
03/01/2025
VALNEVA Declaration of shares and voting rights December 31, 2024 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 décembre 2024
03/01/2025
VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2024 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
Psychiatric Times® celebrates 40 years at the forefront of psychiatry
03/01/2025
CRANBURY, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Psychiatric Times ® has been the voice of psychiatry for 40 years. John L. Schwartz, M.D., introduced this innovative platform in 1985 to foster honest and unbiased [...]
Intuitive Announces Executive Leadership Changes to Support Continued Global Growth
03/01/2025
Three executive vice president promotions strengthen core company strategic leadership SUNNYVALE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care [...]
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
03/01/2025
David Lazar agrees to invest $3.1 million in Preferred Stock and becomes Interim CEO BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or [...]
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
03/01/2025
SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present [...]
Energroup Holdings Corp (OTC: ENHD) to Acquire Cocannco Inc.
03/01/2025
Energroup to acquire a revenue-generating company and remove its "shell" status SACRAMENTO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Energroup Holdings Corp. (OTC: ENHD) today announced plans to acquire Cocannco Inc. [...]
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
03/01/2025
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (" [...]
Safety Shot Launches Revolutionary On-the-Go Stick Packs, Poised to Disrupt the $2 Billion Wellness Market
03/01/2025
JUPITER, Fla., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company”) today announced a breakthrough in convenient wellness solutions with the launch of its Sure Shot On-the-Go Powder Stick [...]
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
03/01/2025
PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the closing of [...]

Pages